Skip to main content
. 2022 Nov 21;10:1047595. doi: 10.3389/fped.2022.1047595

Table 2.

Comparison of clinical outcomes and adverse reactions between Biapenem group and Meropenem group before and after matching.

Variables, n (%) Original cohort Matched cohort
Biapenem (n = 211) Meropenem (n = 704) p Biapenem (n = 208) Meropenem (n = 208) p
Effective 190 (90.00) 636 (90.3) 1.0 188 (90.4) 189 (90.9) 1.0
ADR 16 (7.6) 49 (7.0) 0.876 16 (7.7) 15 (7.2) 1.0